Research Alliance CORP Iv Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Research Alliance Holdings IV LLC and Matthew Hammond have jointly filed a Schedule 13D, reporting beneficial ownership of 17.0% of Research Alliance Corporation IV's Class A Ordinary Shares following the company's IPO and private placement.